Rational diagnoses of diabetes: the comparison of 1,5-anhydroglucitol with other glycemic markers
- PMID: 26543722
- PMCID: PMC4628038
- DOI: 10.1186/s40064-015-1389-5
Rational diagnoses of diabetes: the comparison of 1,5-anhydroglucitol with other glycemic markers
Abstract
Diabetes mellitus (DM) is a frequently encountered disease with important morbidity and mortality. The aim of this study is to document the importance of 1,5-anhydroglucitol (1,5-AG) for the diagnosis of prediabetes and DM, as well as to compare the 1,5-AG with other glycemic markers in order to understand which one is the better diagnostic tool. Between April 2012 and December 2012, 128 participants enrolled in the study. Participants were split into five groups that are IFG, IGT, IFG+IGT, diabetic and control groups by their OGTT results. The diagnostic value of markers was compared by ROC (receiver operating characteristic) method. The mean serum 1,5-AG levels in the diabetic group (33.38 nmol/ml) were lower than, IFG (59.83 nmol/ml), IGT (54.44 nmol/ml), IFG+IGT (51.98 nmol/ml) and control groups (73.24 nmol/ml). When analyzed in the total study population serum 1,5-AG levels did not differ by gender significantly. When analyzed in the total study population, 1,5-AG correlates inversely with age significantly (p = 0.036). In subgroup analysis, in the control group, serum 1,5-AG level was also inversely correlated with age (p = 0.087). The best marker for the diagnosis of prediabetes and DM was fasting plasma glucose (FPG). 1,5-AG was not found to be effective for the diagnosis of DM. This study, contributes to our knowledge of the efficiency and cut-off values of 1,5-AG for the diagnosis of prediabetes and DM. In future, there is a need for larger studies with more standardized and commonly used measurement methods for 1,5-AG, in order to evaluate the efficiency of 1,5-AG for the diagnosis of prediabetes and DM.
Keywords: 1,5-Anhydroglucitol; Diabetes mellitus; Diagnosis; Fructosamine; Glycated hemoglobin; Prediabetes.
Figures
Similar articles
-
Serum 1,5-Anhydroglucitol Concentrations Remain Valid as a Glycemic Control Marker In Diabetes with Earlier Chronic Kidney Disease Stages.Exp Clin Endocrinol Diabetes. 2019 Apr;127(4):220-225. doi: 10.1055/s-0043-122142. Epub 2017 Dec 21. Exp Clin Endocrinol Diabetes. 2019. PMID: 29270924
-
Relationship of glycemic control markers - 1,5 anhydroglucitol, fructosamine, and glycated hemoglobin among Asian Indians with different degrees of glucose intolerance.Indian J Endocrinol Metab. 2016 Sep-Oct;20(5):690-695. doi: 10.4103/2230-8210.190559. Indian J Endocrinol Metab. 2016. PMID: 27730082 Free PMC article.
-
[Cut-off points of fasting fingertip capillary blood glucose for detecting both undiagnosed diabetes and pre-diabetes].Zhonghua Liu Xing Bing Xue Za Zhi. 2010 Oct;31(10):1174-8. Zhonghua Liu Xing Bing Xue Za Zhi. 2010. PMID: 21162825 Clinical Trial. Chinese.
-
Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention.Diabet Med. 2002 Sep;19(9):708-23. doi: 10.1046/j.1464-5491.2002.00835.x. Diabet Med. 2002. PMID: 12207806 Review.
-
Alternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitol.Ann Pediatr Endocrinol Metab. 2015 Jun;20(2):74-8. doi: 10.6065/apem.2015.20.2.74. Epub 2015 Jun 30. Ann Pediatr Endocrinol Metab. 2015. PMID: 26191510 Free PMC article. Review.
Cited by
-
Associations of 1,5-Anhydroglucitol and 2-Hour Glucose with Major Clinical Outcomes in the Atherosclerosis Risk in Communities (ARIC) Study.J Appl Lab Med. 2020 Nov 1;5(6):1296-1306. doi: 10.1093/jalm/jfaa066. J Appl Lab Med. 2020. PMID: 32529222 Free PMC article.
-
Low 1,5-anhydroglucitol levels are associated with long-term cardiac mortality in acute coronary syndrome patients with hemoglobin A1c levels less than 7.0.Cardiovasc Diabetol. 2017 Nov 21;16(1):151. doi: 10.1186/s12933-017-0636-1. Cardiovasc Diabetol. 2017. PMID: 29157245 Free PMC article.
-
Potential Markers of Dietary Glycemic Exposures for Sustained Dietary Interventions in Populations without Diabetes.Adv Nutr. 2020 Sep 1;11(5):1221-1236. doi: 10.1093/advances/nmaa058. Adv Nutr. 2020. PMID: 32449931 Free PMC article.
-
Serum levels of 1,5-anhydroglucitol and 1,5-anhydrofructose-derived advanced glycation end products in patients undergoing hemodialysis.Diabetol Metab Syndr. 2021 Aug 16;13(1):85. doi: 10.1186/s13098-021-00685-w. Diabetol Metab Syndr. 2021. PMID: 34399831 Free PMC article.
-
Pregnancy Toxemia in Ewes: A Review of Molecular Metabolic Mechanisms and Management Strategies.Metabolites. 2023 Jan 18;13(2):149. doi: 10.3390/metabo13020149. Metabolites. 2023. PMID: 36837768 Free PMC article. Review.
References
-
- Armbruster DA. Fructosamine: structure, analysis, and clinical usefulness. Clin Chem. 1987;33(12):2153–2163. - PubMed
-
- Frattali AL, Wolf BA. 1.5-Anhydroglucitol: a novel serum marker for screening and monitoring diabetes mellitus? Clin Chem. 1994;40(11):1991–1993. - PubMed
-
- Herman WH, Dungan KM, Wolffenbuttel BHR, Buse JB, Fahrbach JL, Jiang H, Martin S. Racial and ethnic differences in mean plasma glucose, hemoglobin A1c, and 1,5-anhydroglucitol in over 2000 patients with type 2 diabetes. J Clin Endocrinol Metab. 2009;94(5):1689–1694. doi: 10.1210/jc.2008-1940. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous